| |
| |
|
| Insider
Information: |
Loy Bertrand |
| Relationship: |
Director |
| City: |
Acton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
323,083 |
|
|
Indirect Shares
|
499,633 |
|
|
| Direct
Value |
$33,417,985 |
|
|
|
Indirect Value
|
$1,583,837 |
|
|
| Total
Shares |
822,716 |
|
|
| Total
Value |
$35,001,821 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
0
|
|
Stock
price went up :
|
7
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
7.0
|
0.0
|
| Percentage
Gain/Loss : |
 71.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Entegris Inc |
ENTG |
President & CEO, Direc... |
2024-04-01 |
263,068 |
2021-08-11 |
0 |
Premium* |
|
|
BTU International Inc |
BTUI |
Director |
2016-01-26 |
3,440 |
2016-01-26 |
0 |
Premium* |
|
|
Harvard Bioscience Inc |
HBIO |
Director |
2024-05-21 |
56,575 |
2024-05-21 |
499,633 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
177 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
149,850 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
40,948 |
586,254 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2019-02-19 |
4 |
D |
$34.36 |
$858,210 |
D/D |
(24,977) |
561,277 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2019-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
61,458 |
622,735 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2019-02-25 |
4 |
D |
$37.05 |
$1,011,020 |
D/D |
(27,288) |
595,447 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
35,100 |
184,950 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,600 |
191,550 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-09-11 |
4 |
B |
$3.01 |
$46,926 |
D/D |
15,590 |
138,674 |
2.39 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-09-12 |
4 |
B |
$3.07 |
$34,682 |
D/D |
11,297 |
149,971 |
2.39 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-09-13 |
4 |
B |
$3.11 |
$22,927 |
D/D |
7,372 |
157,343 |
2.39 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-11-08 |
4 |
B |
$2.64 |
$17,466 |
D/D |
6,616 |
163,959 |
2.39 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-11-11 |
4 |
B |
$2.59 |
$33,294 |
D/D |
12,855 |
176,814 |
2.39 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-11-12 |
4 |
B |
$2.51 |
$26,553 |
D/D |
10,579 |
187,393 |
2.39 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-11-13 |
4 |
B |
$2.52 |
$15,372 |
D/D |
6,100 |
193,493 |
2.39 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
223,493 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2020-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
30,868 |
626,315 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2020-02-18 |
4 |
D |
$56.40 |
$967,147 |
D/D |
(17,148) |
647,832 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2020-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
38,665 |
664,980 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2020-02-19 |
4 |
D |
$57.96 |
$1,289,900 |
D/D |
(22,255) |
625,577 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2020-03-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
91,000 |
534,577 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2020-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
91,000 |
91,000 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2020-06-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,767) |
221,726 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2020-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
28,100 |
249,826 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2020-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,300 |
251,126 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2020-07-24 |
4 |
D |
$67.44 |
$6,409,835 |
D/D |
(95,045) |
610,520 |
0 |
- |
|
177 Records found
|
|
Page 5 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
